Health Logic Interactive Inc. ("Health Logic" or the "Company") (TSXV: CHIP.H)(OTCPK: CHYPF), is pleased to announce its wholly-owned operating subsidiary, My Health Logic Inc. ("My Health Logic"), has received a letter of support on the Company's chronic kidney disease (CKD) technology from nephrologist Chirag R. Parikh, MD, PhD Director, Division of Nephrology at Johns Hopkins University School of Medicine. This letter supports the Company's belief that its lab-on-chip device for the early detection of CKD has the potential to address a large and unmet need of patients who have, or are at risk for developing, CKD.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Catalent Announces Upsizing and Pricing of Private Offering of Senior Unsecured Notes Due 2029
February 10, 2021 GMT
SOMERSET, N.J. (BUSINESS WIRE) Feb 10, 2021
Catalent, Inc. (“Catalent”) (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that its wholly owned subsidiary, Catalent Pharma Solutions, Inc. (the “Operating Subsidiary”), priced a private offering (the “Private Offering”) of $550 million in aggregate principal amount of 3.125% senior unsecured notes due 2029 (the “Notes”) at par, which represents an increase of $75 million from the offering size previously announced.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Catalent Announces Launch of Private Offering of $475 Million of Senior Unsecured Notes Due 2029
February 10, 2021 GMT
SOMERSET, N.J. (BUSINESS WIRE) Feb 10, 2021
Catalent, Inc. (“Catalent”) (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that its wholly owned subsidiary, Catalent Pharma Solutions, Inc. (the “Operating Subsidiary”), intends to offer, subject to market and other conditions, $475 million in aggregate principal amount of senior unsecured notes due 2029 (the “Notes”) in a private offering (the “Private Offering”) that is exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”).